Quantitative Gait Analysis Detects Significant Differences in Movement between Osteoarthritic and Nonosteoarthritic Guinea Pig Strains before and after Treatment with Flunixin Meglumine
A computer-aided gait analysis system was used to contrast two guinea pig strains with differing propensity for osteoarthritis (OA), with/without administration of a nonsteroidal anti-inflammatory drug. Walking speed and static/dynamic gait parameters were determined at baseline. Flunixin meglumine was given and animals were evaluated 4, 24, and 72 hours after treatment. Body weight was compared using unpaired -tests. Knee joints were histologically evaluated using species-specific criteria; indices were analyzed using one-way ANOVA, Kruskal-Wallis test, followed by Dunn’s multiple comparisons. A generalized linear model followed by Tukey’s posttests juxtaposed gait parameters; walking speed was a covariate for other outcome measures. Body weight was not different between strains; OA-prone animals demonstrated more progressive chondropathy. At baseline, OA-prone animals had slower walking speeds, narrower hind limb bases of support, shorter stride lengths, and slower limb swing speeds relative to OA-resistant animals. These differences were not detected 4 or 24 hours after treatment. By 72 hours, OA-prone animals had returned to baseline values. These findings indicate a distinct voluntary gait pattern in a rodent model of bilateral primary OA, modification of which may allow rapid screening of novel therapies. Flunixin meglumine temporarily permitted OA-prone animals to move in a manner that was analogous to OA-resistant animals. 1. Introduction The major clinical symptom associated with osteoarthritis (OA) is pain during motion. Unfortunately, the severity of joint disease determined via imaging and histology is often only weakly associated with the chief complaint [1]. As disturbances in movement are known consequences of pain [2], analyses of gait in parallel with standard measures of pathology have started to find favor with animal models of human disease. Techniques utilized to evaluate OA in rodents include assessment of musculoskeletal function (grip strength meters, rotarod testing) and gait and spontaneous activity testing (force platforms, video-recorded open-field and arena trials) [3]. Walkway- [4] and treadmill-associated [5] computer-aided gait analysis systems have also been validated to gauge gait abnormalities in injury-induced models of arthritis. An automated quantitative gait analysis method, the Noldus CatWalk, determines a large number of locomotion parameters in laboratory animals during spontaneous, unforced platform crossing [6]. This computer-assisted method objectively and rapidly monitors a large number of both dynamic and
References
[1]
P. A. Dieppe and L. S. Lohmander, “Pathogenesis and management of pain in osteoarthritis,” The Lancet, vol. 365, no. 9463, pp. 965–973, 2005.
[2]
C. E. Ferland, F. Beaudry, and P. Vachon, “Antinociceptive effects of eugenol evaluated in a monoiodoacetate-induced osteoarthritis rat model,” Phytotherapy Research, vol. 26, no. 9, pp. 1278–1285, 2012.
[3]
T. M. Griffin, B. Fermor, J. L. Huebner et al., “Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice,” Arthritis Research and Therapy, vol. 12, no. 4, article R130, 2010.
[4]
K. ?. M?ller, O.-G. Berge, and F. P. T. Hamers, “Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib,” Journal of Neuroscience Methods, vol. 174, no. 1, pp. 1–9, 2008.
[5]
A. Plaas, J. Li, J. Riesco, R. Das, J. D. Sandy, and A. Harrison, “Intraarticular injection of hyaluronan prevents cartilage erosion, periarticular fibrosis and mechanical allodynia and normalizes stance time in murine knee osteoarthritis,” Arthritis Research and Therapy, vol. 13, no. 2, article R46, 2011.
[6]
G. C. Koopmans, R. Deumens, W. M. M. Honig, F. P. T. Hamers, H. W. M. Steinbusch, and E. A. J. Joosten, “The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination,” Journal of Neurotrauma, vol. 22, no. 2, pp. 214–225, 2005.
[7]
M. H. Hoffmann, R. Hopf, B. Niederreiter, H. Redl, J. S. Smolen, and G. Steiner, “Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis,” Arthritis Research and Therapy, vol. 12, no. 2, article R41, 2010.
[8]
C. E. Ferland, S. Laverty, F. Beaudry, and P. Vachon, “Gait analysis and pain response of two rodent models of osteoarthritis,” Pharmacology Biochemistry and Behavior, vol. 97, no. 3, pp. 603–610, 2011.
[9]
J. Ferreira-Gomes, S. Ad?es, M. Mendon?a, and J. M. Castro-Lopes, “Analgesic effects of lidocaine, morphine and diclofenac on movement-induced nociception, as assessed by the Knee-Bend and CatWalk tests in a rat model of osteoarthritis,” Pharmacology Biochemistry and Behavior, vol. 101, no. 4, pp. 617–624, 2012.
[10]
V. B. Kraus, J. L. Huebner, J. DeGroot, and A. Bendele, “The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the guinea pig,” Osteoarthritis and Cartilage, vol. 18, supplement 3, pp. S35–S52, 2010.
[11]
N. Schuelert, M. P. Johnson, J. L. Oskins, K. Jassal, M. G. Chambers, and J. J. McDougall, “Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis,” Pain, vol. 152, no. 5, pp. 975–981, 2011.
[12]
J. L. Huebner, M. A. Hanes, B. Beekman, J. M. TeKoppele, and V. B. Kraus, “A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis,” Osteoarthritis and Cartilage, vol. 10, no. 10, pp. 758–767, 2002.
[13]
Y. C. Lee, “Effect and treatment of chronic pain in inflammatory arthritis,” Current Rheumatology Reports, vol. 15, no. 1, article 300, 2013.
[14]
A. A. Abu-Ghefreh and W. Masocha, “Enhancement of antinociception by coadminstration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in nave mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis,” BMC Musculoskeletal Disorders, vol. 11, article 276, 2010.
[15]
Y. Amagai, A. Matsuda, K. Oida et al., “Topical application of ketoprofen improves gait disturbance in rat models of acute inflammation,” BioMed Research International, vol. 2013, Article ID 540231, 7 pages, 2013.
[16]
L. R. Goodrich and A. J. Nixon, “Medical treatment of osteoarthritis in the horse—a review,” Veterinary Journal, vol. 171, no. 1, pp. 51–69, 2006.
[17]
K. S. Santangelo, E. M. Pieczarka, G. J. Nuovo, S. E. Weisbrode, and A. L. Bertone, “Temporal expression and tissue distribution of interleukin-1β in two strains of guinea pigs with varying propensity for spontaneous knee osteoarthritis,” Osteoarthritis and Cartilage, vol. 19, no. 4, pp. 439–448, 2011.
[18]
K. D. Allen, B. A. Mata, M. A. Gabr et al., “Kinematic and dynamic gait compensations resulting from knee instability in a rat model of osteoarthritis,” Arthritis Research and Therapy, vol. 14, no. 2, article R78, 2012.
[19]
W. Masocha and S. S. Pavarthy, “Assessment of weight bearing changes and pharmacological antinociception in mice with LPS-induced monoarthritis using the Catwalk gait analysis system,” Life Sciences, vol. 85, no. 11-12, pp. 462–469, 2009.
[20]
J. Ferreira-Gomes, S. Ad?es, and J. M. Castro-Lopes, “Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study,” Journal of Pain, vol. 9, no. 10, pp. 945–954, 2008.
[21]
J. Ferreira-Gomes, S. Ad?es, R. M. Sousa, M. Mendon?a, and J. M. Castro-Lopes, “Dose-dependent expression of neuronal injury markers during experimental osteoarthritis induced by monoiodoacetate in the rat,” Molecular Pain, vol. 8, article 50, 2012.
[22]
S. S. Parvathy and W. Masocha, “Gait analysis of C57BL/6 mice with complete Freund's adjuvant-induced arthritis using the CatWalk system,” BMC Musculoskeletal Disorders, vol. 14, article 14, 2013.
[23]
P. A. Dieppe and L. S. Lohmander, “Pathogenesis and management of pain in osteoarthritis,” The Lancet, vol. 365, no. 9463, pp. 965–973, 2005.